Abstract Number: 1487 • 2015 ACR/ARHP Annual Meeting
Tocilizumab in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis in Patients Who Have Failed to Disease-Modifying Antirheumatic Drugs: Long Term Results of the Brazilian Cohort
Background/Purpose: Tocilizumab is a humanized monoclonal antibody that binds to IL-6 receptor, blocking its effects. The efficacy and safety of tocilizumab in rheumatoid arthritis (RA)…Abstract Number: 1488 • 2015 ACR/ARHP Annual Meeting
Following the American College of Rheumatology Quality Guidelines Can Enhance the Safety of Rheumatoid Arthritis Patients Treated with Disease Modifying Drugs
Background/Purpose: Adverse events (AEs) and serious adverse events (SAEs) from disease modifying drugs (DMARDs) for Rheumatoid Arthritis (RA) can result in significant morbidity and even…Abstract Number: 1489 • 2015 ACR/ARHP Annual Meeting
Promoting Smoking Cessation Among Rheumatoid Arthritis Patients: What Motivations and Barriers Are Reported after Being Offered a Smoking Cessation Intervention?
Background/Purpose: Patients with rheumatoid arthritis (RA) may experience specific barriers to smoking cessation but may also be motivated to quit to improve their health, particularly…Abstract Number: 1490 • 2015 ACR/ARHP Annual Meeting
Can Patients Forget Their Artificial Joint after Arthroplasty?
Background/Purpose: Knee and hip osteoarthritis (OA) are the clinical outcome of a functional and structural failure resulting with pain and physical dysfunction. Total joint arthroplasty…Abstract Number: 1491 • 2015 ACR/ARHP Annual Meeting
Effects of Drug Induced Toxicity on Patient Reported Outcomes in Early Rheumatoid Arthritis Treated-to-Target Using Conventional Triple DMARD Therapy
Background/Purpose: While the introduction of the treat-to-target (T2T) strategy is associated with lower disease activity scores in rheumatoid arthritis (RA), the potential for increased toxicity…Abstract Number: 1492 • 2015 ACR/ARHP Annual Meeting
Implementation in Clinical Practice of a Medication Assessment Tool Specific for Rheumatoid Arthritis, Rhmat
Background/Purpose: The RhMAT is a medication assessment tool developed to specifically analyse pharmacotherapy adherence to evidence based medicine and guidelines on the management of rheumatoid…Abstract Number: 1493 • 2015 ACR/ARHP Annual Meeting
Adherence in Patients Who Are on Stable Doses of Methotrexate
Background/Purpose: Methotrexate has become the mainstay of DMARD treatment in Rheumatoid Arthritis and is also used in other rheumatological conditions. It is a drug that…Abstract Number: 1494 • 2015 ACR/ARHP Annual Meeting
The Role of a Nurse-Led Clinic in the Assessment and Prevention of Cardio-Vascular Risk
Background/Purpose: Patients with chronic arthritis have a higher risk of cardiovascular (CV) events than the general population. This is possibly due to the combination of…Abstract Number: 1495 • 2015 ACR/ARHP Annual Meeting
Person-Centred Care Can Help Patients to Become More Effective Consumers in the Use of Health Information Than Regular Care – an RCT in Patients with Arthritis Undergoing Biological Therapy
Background/Purpose: Person-centred care (PCC) is a holistic approach with respectful and individualized care allowing negotiation of care where persons with health problems are empowered to…Abstract Number: 1496 • 2015 ACR/ARHP Annual Meeting
Uncovering and Addressing Issues Related to Medication Adherence Among Patients with Rheumatic Diseases: A Patient Navigator Pilot Program
Background/Purpose: Poor adherence to medications is a common problem among rheumatology patients that can lead to irreversible negative outcomes. We piloted an intervention using patient…Abstract Number: 1497 • 2015 ACR/ARHP Annual Meeting
Panlar Consensus on Hand, Hip and Knee OA
Background/Purpose: The purpose of this Consensus is to update the PANLAR recommendations for hand, hip and knee osteoarthritis (OA) based on a combination of the…Abstract Number: 1498 • 2015 ACR/ARHP Annual Meeting
Engaging Clinic Staff in Work System Redesign to Adapt a Hypertension Protocol for Rheumatology
Background/Purpose: Despite routine blood pressure (BP) measurement by clinic staff, we reported that rheumatologists discussed elevated BPs in <1/3 of visits leading to missed opportunities…Abstract Number: 1499 • 2015 ACR/ARHP Annual Meeting
Patients Who Take Many Medications for Their Fibromyalgia Symptoms at the Initial Office Visit Tend to Have a Worse Clinical Course
Background/Purpose: Fibromyalgia syndrome (FMS) patients taking a greater number of medications may identify those with a more challenging clinical course. Methods: We evaluated patients at their…Abstract Number: 1500 • 2015 ACR/ARHP Annual Meeting
Impact of Menopause on Functional Impairment of Rheumatoid Arthritis Patients
Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease which is predominant in female with female to male ration ranging between 2:1 to 3:1. The peak…Abstract Number: 1501 • 2015 ACR/ARHP Annual Meeting
Prevalence of Unassessed and Uncontrolled Cardiovascular Disease Risk Factors Among Rheumatoid Arthritis Patients in an Academic Rheumatology Practice
Background/Purpose: Cardiovascular disease (CVD) is the leading cause of death in individuals with rheumatoid arthritis (RA). Patients with RA are at 1.5-2.0-fold increased risk of…
ACR Meeting Abstracts